FRINX | FRIRX | FRINX / FRIRX | |
Total Expense Ratio | 0.95 | 0.70 | 136% |
Annual Report Gross Expense Ratio | 0.95 | 0.70 | 136% |
Fund Existence | 16 years | 16 years | - |
Gain YTD | 6.480 | 6.632 | 98% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.55B | 5.55B | 100% |
Annual Yield % from dividends | 4.32 | 4.54 | 95% |
Returns for 1 year | 4.34 | 4.66 | 93% |
Returns for 3 years | 28.14 | 29.07 | 97% |
Returns for 5 years | 33.09 | 34.89 | 95% |
Returns for 10 years | 58.09 | 62.41 | 93% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PXLIX | 14.34 | 0.06 | +0.42% |
Impax Large Cap Fund Institutional | |||
FIRAX | 10.33 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate A | |||
BIPSX | 29.24 | -0.05 | -0.17% |
ProFunds Biotechnology UltraSector Svc | |||
GEMIX | 29.85 | -0.06 | -0.20% |
Goldman Sachs Emerging Markets Eq Instl | |||
MGICX | 38.10 | -0.26 | -0.68% |
MFS International Intrinsic Value C |